INS and diabetes mellitus: If there is a U-shaped relation between BMI and diabetes, and the pathophysiologic pathway is completely different for low and high BMI (insulin secretion compared with resistance), this may have a major impact when treating diabetes since in Africa, the usual first-line treatment, metformin (2), does not address a key problem of reduced insulin secretion.